East West Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 51.95%
(FY 2023)
- Profit -8.59%
(FY 2023)
- Ebitda -23.48%
(FY 2023)
- Net Worth -46.93%
(FY 2023)
- Total Assets -0.36%
(FY 2023)
About East West Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balaraman Mohankumar and Sabarish Mohankumar serve as directors at the Company.
- CIN/LLPIN
U24232TZ2005PTC028945
- Company No.
028945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2005
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at East West Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sabarish Mohankumar  | Director | 29-Mar-2019 | Current |
| Balaraman Mohankumar | Director | 17-Mar-2005 | Current |
Financial Performance of East West Formulations.
East West Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51.95% increase. The company also saw a slight decrease in profitability, with a 8.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of East West Formulations?
Unlock access to East West Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Omkar Medical Distributors Private LimitedActive 17 years 7 monthsBalaraman Mohankumar is a mutual person
East West Pharma India Private LimitedActive 4 years 11 monthsBalaraman Mohankumar and Sabarish Mohankumar are mutual person
- Ewp Pharma & Lifecare Remedies Private LimitedActive 5 years 9 months
Balaraman Mohankumar and Sabarish Mohankumar are mutual person
- Vedhsang Private LimitedActive 2 years 20 days
Balaraman Mohankumar and Sabarish Mohankumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at East West Formulations?
Unlock and access historical data on people associated with East West Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of East West Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped East West Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
